Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

Authors: Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Yin Chen, Li-Hua Hou, Jing-Xian Liu, Jin Zhong, Hongxing Pan, Fengjuan Shi, Xiaoyu Xu, Zhuo-Pei Li, Xiao-Yin Zhang, Lunbiao Cui, Wenjie Tan, Wei Chen, Fengcai Zhu, Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Yin Chen, Li-Hua Hou, Jing-Xian Liu, Jin Zhong, Hongxing Pan, Fengjuan Shi, Xiaoyu Xu, Zhuo-Pei Li, Xiao-Yin Zhang, Lunbiao Cui, Wenjie Tan, Wei Chen, Fengcai Zhu, Hai-Tao Huang, Jin-Bo Gou, Weixue Si, Xue Wang, Xiaolong Zhao, Tao Zhu - The Lancet 2022 cited by 170